Categories: News

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2023

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Disclosure of Share Capital and Voting Rights Outstanding
as of March 31, 2023

(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Charenton-le-Pont, France (April 14, 20236:30 pm) – As of March 31, 2023, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.

  March 31, 2023
Shares outstanding 447,691,5871
Number of real voting rights (excluding treasury shares) 445,231,933
Theoretical number of voting rights (including treasury shares) 447,691,587

It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained in article 23 of EssilorLuxottica’s by-laws2.

For further information, please consult the Prospectus which received Visa No. 18-460 from the AMF on September 28, 2018 and its Securities Note Supplement which received Visa No. 18-494 from the AMF on October 23, 2018, available on the website www.essilorluxottica.com.

1Including 3,354 shares delivered but not yet registered as of March 31, 2023.
2EssilorLuxottica’s by-laws are available on the Company’s website under the section Governance / Publications.

Attachment

Staff

Recent Posts

Vinamilk Showcases Science-Driven Innovation and Wins Prestigious Awards at Global Dairy Congress 2025

AMSTERDAM, June 26, 2025 /PRNewswire/ -- Vinamilk, Vietnam's leading dairy company, presented its science-driven innovation…

2 hours ago

Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain

ARLINGTON, Va., June 26, 2025 /PRNewswire/ -- A new survey of 195 diagnostic imaging and…

8 hours ago

Ultima Genomics Selected to Support the World’s Largest Proteomics Studies to Date Led by Regeneron Genetics Center

FREMONT, Calif., June 26, 2025 /PRNewswire/ -- Ultima Genomics, a developer of an innovative new…

8 hours ago

Therap Enhances Secure Document Signing with Added ‘Order’ Module Search Option in Reference Module Dropdown

TORRINGTON, Conn., June 26, 2025 /PRNewswire/ -- Therap Services, the leading provider of HIPAA-compliant electronic documentation…

8 hours ago

Los Angeles Center for Ear, Nose, Throat and Allergy Introduces Clarity Technologies’ New Audiology Video Library

Cutting-edge tool aims to enhance patient education and experience while improving operational efficiency LOS ANGELES,…

8 hours ago